The legal action, filed in the U.S. District Court for the District of New Jersey, centers on communications issued between November 25, 2025, and May 4, 2026. During this period, Embecta management repeatedly characterized its core portfolio as stable and resolute. Plaintiffs contend these assurances masked a reality of deteriorating performance that executives either knew about or recklessly disregarded.

The discrepancy surfaced on May 5, 2026, when the company released second-quarter fiscal results that contradicted previous guidance. Embecta slashed its full-year 2026 adjusted earnings per share projection by roughly 43% and cut its quarterly dividend by 93%, dropping the payout from $0.15 to $0.01 per share. Hagens Berman, the law firm spearheading the investigation, is now reviewing whether these prior statements constituted actionable securities fraud. Investors who incurred losses during the class period have until August 17, 2026, to seek lead plaintiff status.